TY - JOUR AU - Schwartz, M. W. AU - Seeley, R. J. AU - Zeltser, L. M. AU - Drewnowski, A. AU - Ravussin, E. AU - Redman, L. M. PY - 2017 DA - 2017// TI - Obesity pathogenesis: an endocrine society scientific statement JO - Endocr Rev VL - 38 UR - https://doi.org/10.1210/er.2017-00111 DO - 10.1210/er.2017-00111 ID - Schwartz2017 ER - TY - JOUR AU - Poirier, P. PY - 2006 DA - 2006// TI - Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 american heart association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism JO - Circulation VL - 113 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.171016 DO - 10.1161/CIRCULATIONAHA.106.171016 ID - Poirier2006 ER - TY - JOUR AU - Zhang, Y. AU - Liu, J. AU - Yao, J. AU - Ji, G. AU - Qian, L. AU - Wang, J. PY - 2014 DA - 2014// TI - Obesity: pathophysiology and intervention JO - Nutrients. VL - 6 UR - https://doi.org/10.3390/nu6115153 DO - 10.3390/nu6115153 ID - Zhang2014 ER - TY - STD TI - World Health Organization. Fact sheet—obesity and overweight. 2018. http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. UR - http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight ID - ref4 ER - TY - JOUR AU - Vassallo, J. PY - 2007 DA - 2007// TI - Pathogenesis of obesity JO - J Malta Coll Pharm Pract VL - 12 ID - Vassallo2007 ER - TY - JOUR AU - Leite, L. AU - Rocha, E. AU - Brandão-Neto, J. PY - 2009 DA - 2009// TI - Obesidade: uma doença inflamatória JO - Revista Ciência Saúde. VL - 2 UR - https://doi.org/10.15448/1983-652X.2009.2.6238 DO - 10.15448/1983-652X.2009.2.6238 ID - Leite2009 ER - TY - JOUR AU - Litwin, S. E. PY - 2008 DA - 2008// TI - Which measures of obesity best predict cardiovascular risk? JO - J Am Coll Cardiol VL - 52 UR - https://doi.org/10.1016/j.jacc.2008.05.017 DO - 10.1016/j.jacc.2008.05.017 ID - Litwin2008 ER - TY - JOUR AU - Souza, A. AU - Arantes, B. AU - Costa, P. PY - 2008 DA - 2008// TI - A obesidade como fator de risco para doenças cardiovasculares JO - Rev Edu Meio Amb e Saúde. VL - 3 ID - Souza2008 ER - TY - CHAP AU - Crane, J. a. m. e. s. D. AU - McGowan, B. a. r. b. a. r. a. M. PY - 2017 DA - 2017// TI - Clinical Assessment of the Patient with Overweight or Obesity BT - Endocrinology PB - Springer International Publishing CY - Cham ID - Crane2017 ER - TY - CHAP AU - Al-Najim, W. e. r. d. AU - le Roux, C. a. r. e. l. W. PY - 2018 DA - 2018// TI - An Integrated View of Treatment Options Available for Obesity BT - Endocrinology PB - Springer International Publishing CY - Cham ID - Al-Najim2018 ER - TY - JOUR AU - Hruby, A. AU - Hu, F. B. PY - 2015 DA - 2015// TI - The epidemiology of obesity: a big picture JO - Pharmacoeconomics. VL - 33 UR - https://doi.org/10.1007/s40273-014-0243-x DO - 10.1007/s40273-014-0243-x ID - Hruby2015 ER - TY - JOUR AU - Gomes, F. AU - Telo, D. AU - Souza, H. AU - Nicolau, J. AU - Halpern, A. AU - Serrano, C. PY - 2010 DA - 2010// TI - Obesity and coronary artery disease: role of vascular inflammation JO - Arq Bras Cardiol VL - 94 UR - https://doi.org/10.1590/S0066-782X2010000200021 DO - 10.1590/S0066-782X2010000200021 ID - Gomes2010 ER - TY - JOUR AU - Carvalho, M. AU - Colaço, A. AU - Fortes, Z. PY - 2006 DA - 2006// TI - Citocinas, disfunção endotelial e resistência à insulina JO - Arq Bras Endocrinol Metab. VL - 50 UR - https://doi.org/10.1590/S0004-27302006000200016 DO - 10.1590/S0004-27302006000200016 ID - Carvalho2006 ER - TY - CHAP AU - Gandhi, H. AU - Balaraman, R. PY - 2013 DA - 2013// TI - Involvement of adipocytokines in pathogenesis of insulin resistance, obesity, and metabolic syndrome BT - Metabolic syndrome and neurological disorders PB - Wiley CY - New York ID - Gandhi2013 ER - TY - JOUR AU - Bravo, P. AU - Morse, S. AU - Borne, D. AU - Aguilar, E. AU - Reisin, E. PY - 2006 DA - 2006// TI - Leptin and hypertension in obesity JO - Vasc Health Risk Manag VL - 2 UR - https://doi.org/10.2147/vhrm.2006.2.2.163 DO - 10.2147/vhrm.2006.2.2.163 ID - Bravo2006 ER - TY - JOUR AU - Pradhan, G. AU - Samson, S. AU - Sun, Y. PY - 2013 DA - 2013// TI - Ghrelin: much more than a hunger hormone JO - Curr Opin Clin Nutr Metab Care. VL - 16 UR - https://doi.org/10.1097/MCO.0b013e328365b9be DO - 10.1097/MCO.0b013e328365b9be ID - Pradhan2013 ER - TY - JOUR AU - Szmitko, P. AU - Leiter, L. AU - Verma, S. PY - 2010 DA - 2010// TI - The incretin system and cardiometabolic disease JO - Can J Cardiol VL - 26 UR - https://doi.org/10.1016/S0828-282X(10)70010-6 DO - 10.1016/S0828-282X(10)70010-6 ID - Szmitko2010 ER - TY - JOUR AU - Khat, D. Z. AU - Husain, M. PY - 2018 DA - 2018// TI - Molecular mechanisms underlying the cardiovascular benefits of SGLT2i and GLP-1RA JO - Curr Diab Rep. VL - 18 UR - https://doi.org/10.1007/s11892-018-1011-7 DO - 10.1007/s11892-018-1011-7 ID - Khat2018 ER - TY - JOUR AU - Ley, R. AU - Turnbaugh, P. AU - Klein, S. PY - 2006 DA - 2006// TI - Microbial ecology: human gut microbes associated with obesity JO - Nature. VL - 444 UR - https://doi.org/10.1038/4441022a DO - 10.1038/4441022a ID - Ley2006 ER - TY - JOUR AU - Turnbaugh, P. AU - Backhed, F. AU - Fulton, L. PY - 2008 DA - 2008// TI - Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome JO - Cell Host Microbe. VL - 3 UR - https://doi.org/10.1016/j.chom.2008.02.015 DO - 10.1016/j.chom.2008.02.015 ID - Turnbaugh2008 ER - TY - JOUR AU - Turnbaugh, P. AU - Hamady, M. AU - Yatsunenko, T. AU - Cantarel, B. AU - Duncan, A. AU - Ley, R. PY - 2009 DA - 2009// TI - A core gut microbiome in obese and lean twins JO - Nature. VL - 457 UR - https://doi.org/10.1038/nature07540 DO - 10.1038/nature07540 ID - Turnbaugh2009 ER - TY - JOUR AU - Saad, M. AU - Santos, A. AU - Prada, P. PY - 2016 DA - 2016// TI - Linking gut microbiota and inflammation to obesity and insulin resistance JO - Physiology (Bethesda). VL - 31 ID - Saad2016 ER - TY - JOUR AU - Barroso, T. A. AU - Marins, L. B. AU - Alves, R. AU - Gonçalves, A. C. S. AU - Barroso, S. G. AU - Rocha, G. D. S. PY - 2017 DA - 2017// TI - Association of central obesity with the incidence of cardiovascular diseases and risk factors JO - Int J Cardiovasc Sci VL - 30 ID - Barroso2017 ER - TY - JOUR AU - Akil, L. AU - Ahmad, H. A. PY - 2011 DA - 2011// TI - Relationships between obesity and cardiovascular diseases in four southern states and Colorado JO - J Health Care Poor Underserved VL - 22 UR - https://doi.org/10.1353/hpu.2011.0166 DO - 10.1353/hpu.2011.0166 ID - Akil2011 ER - TY - JOUR AU - Unamuno, X. AU - Gomez-Ambrosi, J. AU - Rodriguez, A. AU - Becerril, S. AU - Fruhbeck, G. AU - Catalan, V. PY - 2018 DA - 2018// TI - Adipokine dysregulation and adipose tissue inflammation in human obesity JO - Eur J Clin Invest VL - 48 UR - https://doi.org/10.1111/eci.12997 DO - 10.1111/eci.12997 ID - Unamuno2018 ER - TY - JOUR AU - Aprahamian, T. R. AU - Sam, F. PY - 2011 DA - 2011// TI - Adiponectin in cardiovascular inflammation and obesity JO - Int J Inflam. VL - 2011 UR - https://doi.org/10.4061/2011/376909 DO - 10.4061/2011/376909 ID - Aprahamian2011 ER - TY - JOUR AU - Achari, A. E. AU - Jain, S. K. PY - 2017 DA - 2017// TI - Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction JO - Int J Mol Sci. VL - 18 UR - https://doi.org/10.3390/ijms18061321 DO - 10.3390/ijms18061321 ID - Achari2017 ER - TY - JOUR AU - Joao, A. L. AU - Reis, F. AU - Fernandes, R. PY - 2016 DA - 2016// TI - The incretin system ABCs in obesity and diabetes—novel therapeutic strategies for weight loss and beyond JO - Obes Rev VL - 17 UR - https://doi.org/10.1111/obr.12421 DO - 10.1111/obr.12421 ID - Joao2016 ER - TY - JOUR AU - Iscan, S. AU - Yurekli, I. AU - Cakir, H. AU - Gokalp, O. PY - 2017 DA - 2017// TI - Inflammatory activity of adipose tissue JO - Anatol J Cardiol. VL - 17 UR - https://doi.org/10.14744/AnatolJCardiol.2017.7729 DO - 10.14744/AnatolJCardiol.2017.7729 ID - Iscan2017 ER - TY - JOUR AU - Balsan, G. A. AU - Vieira, J. L. AU - Oliveira, A. M. AU - Portal, V. L. PY - 2015 DA - 2015// TI - Relationship between adiponectin, obesity and insulin resistance JO - Rev Assoc Med Bras. VL - 61 UR - https://doi.org/10.1590/1806-9282.61.01.072 DO - 10.1590/1806-9282.61.01.072 ID - Balsan2015 ER - TY - JOUR AU - Rodriguez-Hernandez, H. AU - Simental-Mendia, L. E. AU - Rodriguez-Ramirez, G. AU - Reyes-Romero, M. A. PY - 2013 DA - 2013// TI - Obesity and inflammation: epidemiology, risk factors, and markers of inflammation JO - Int J Endocrinol. VL - 2013 UR - https://doi.org/10.1155/2013/678159 DO - 10.1155/2013/678159 ID - Rodriguez-Hernandez2013 ER - TY - JOUR AU - Mraz, M. AU - Haluzik, M. PY - 2014 DA - 2014// TI - The role of adipose tissue immune cells in obesity and low-grade inflammation JO - J Endocrinol VL - 222 UR - https://doi.org/10.1530/JOE-14-0283 DO - 10.1530/JOE-14-0283 ID - Mraz2014 ER - TY - JOUR AU - Mathew, B. AU - Francis, L. AU - Kayalar, A. AU - Cone, J. PY - 2008 DA - 2008// TI - Obesity: effects on cardiovascular disease and its diagnosis JO - J Am Board Fam Med. VL - 21 UR - https://doi.org/10.3122/jabfm.2008.06.080080 DO - 10.3122/jabfm.2008.06.080080 ID - Mathew2008 ER - TY - JOUR AU - Keane, K. AU - Cruzat, V. AU - Carlessi, R. AU - Bittencourt, P. J. AU - Newsholme, P. PY - 2015 DA - 2015// TI - Molecular events linking oxidative stress and inflammation to insulin resistance and beta-cell dysfunction JO - Oxid Med Cell Longev. VL - 2015 UR - https://doi.org/10.1155/2015/181643 DO - 10.1155/2015/181643 ID - Keane2015 ER - TY - JOUR AU - Giannini, D. AU - Kuschnir, M. AU - Oliveira, C. AU - Bloch, K. AU - Schaan, B. AU - Cureau, F. PY - 2017 DA - 2017// TI - C-reactive protein in Brazilian adolescents: distribution and association with metabolic syndrome in ERICA survey JO - Eur J Clin Nutr VL - 71 UR - https://doi.org/10.1038/ejcn.2017.74 DO - 10.1038/ejcn.2017.74 ID - Giannini2017 ER - TY - JOUR AU - Kaptoge, S. AU - Angelantonio, E. AU - Lowe, G. AU - Pepys, M. AU - Thompson, S. PY - 2010 DA - 2010// TI - C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis JO - Lancet. VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)61717-7 DO - 10.1016/S0140-6736(09)61717-7 ID - Kaptoge2010 ER - TY - JOUR AU - Ridker, P. AU - Libby, P. AU - MacFadyen, J. AU - Thuren, T. AU - Ballantyne, C. AU - Fonseca, F. PY - 2018 DA - 2018// TI - Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) JO - Eur Heart J VL - 39 UR - https://doi.org/10.1093/eurheartj/ehy310 DO - 10.1093/eurheartj/ehy310 ID - Ridker2018 ER - TY - JOUR AU - Zalesin, K. C. AU - Franklin, B. A. AU - Miller, W. M. AU - Peterson, E. D. AU - McCullough, P. A. PY - 2008 DA - 2008// TI - Impact of obesity on cardiovascular disease JO - Endocrinol Metab Clin North Am. VL - 37 UR - https://doi.org/10.1016/j.ecl.2008.06.004 DO - 10.1016/j.ecl.2008.06.004 ID - Zalesin2008 ER - TY - JOUR AU - Owen, M. AU - Noblet, J. AU - Sassoon, D. AU - Conteh, A. AU - Goodwill, A. AU - Tune, J. PY - 2014 DA - 2014// TI - Perivascular adipose tissue and coronary vascular disease JO - Arterioscler Thromb Vasc Biol VL - 34 UR - https://doi.org/10.1161/ATVBAHA.114.303033 DO - 10.1161/ATVBAHA.114.303033 ID - Owen2014 ER - TY - JOUR AU - Antoniades, C. AU - Kotanidis, C. AU - Berman, D. PY - 2019 DA - 2019// TI - State-of-the-art review article. Atherosclerosis affecting fat: what can we learn by imaging perivascular adipose tissue? JO - J Cardiovasc Comput Tomogr. UR - https://doi.org/10.1016/j.jcct.2019.03.006 DO - 10.1016/j.jcct.2019.03.006 ID - Antoniades2019 ER - TY - JOUR AU - Castro, A. M. AU - Concha, L. E. AU - Pantoja-Meléndez, C. A. PY - 2017 DA - 2017// TI - Low-grade inflammation and its relation to obesity and chronic degenerative diseases JO - Revista Médica del Hospital General de México. VL - 80 UR - https://doi.org/10.1016/j.hgmx.2016.06.011 DO - 10.1016/j.hgmx.2016.06.011 ID - Castro2017 ER - TY - JOUR AU - Sun, S. AU - Ji, Y. AU - Kersten, S. AU - Qi, L. PY - 2012 DA - 2012// TI - Mechanisms of inflammatory responses in obese adipose tissue JO - Annu Rev Nutr VL - 32 UR - https://doi.org/10.1146/annurev-nutr-071811-150623 DO - 10.1146/annurev-nutr-071811-150623 ID - Sun2012 ER - TY - JOUR AU - Guzik, T. J. AU - Skiba, D. S. AU - Touyz, R. M. AU - Harrison, D. G. PY - 2017 DA - 2017// TI - The role of infiltrating immune cells in dysfunctional adipose tissue JO - Cardiovasc Res VL - 113 UR - https://doi.org/10.1093/cvr/cvx108 DO - 10.1093/cvr/cvx108 ID - Guzik2017 ER - TY - JOUR AU - Solinas, G. AU - Becattini, B. PY - 2016 DA - 2016// TI - JNK at the crossroad of obesity, insulin resistance, and cell stress response JO - Mol Metab. VL - 6 UR - https://doi.org/10.1016/j.molmet.2016.12.001 DO - 10.1016/j.molmet.2016.12.001 ID - Solinas2016 ER - TY - JOUR AU - Lee, S. Y. AU - Chang, H. J. AU - Sung, J. AU - Kim, K. J. AU - Shin, S. AU - Cho, I. J. PY - 2014 DA - 2014// TI - The impact of obesity on subclinical coronary atherosclerosis according to the risk of cardiovascular disease JO - Obesity (Silver Spring). VL - 22 UR - https://doi.org/10.1002/oby.20760 DO - 10.1002/oby.20760 ID - Lee2014 ER - TY - JOUR AU - Ballegooijen, A. J. AU - Pilz, S. AU - Tomaschitz, A. AU - Grubler, M. R. AU - Verheyen, N. PY - 2017 DA - 2017// TI - The synergistic interplay between vitamins D and K for bone and cardiovascular health: a narrative review JO - Int J Endocrinol. VL - 2017 ID - Ballegooijen2017 ER - TY - JOUR AU - Simonds, S. E. AU - Pryor, J. T. AU - Ravussin, E. AU - Greenway, F. L. AU - Dileone, R. AU - Allen, A. M. PY - 2014 DA - 2014// TI - Leptin mediates the increase in blood pressure associated with obesity JO - Cell VL - 159 UR - https://doi.org/10.1016/j.cell.2014.10.058 DO - 10.1016/j.cell.2014.10.058 ID - Simonds2014 ER - TY - JOUR AU - Oigman, W. AU - Neves, M. PY - 2000 DA - 2000// TI - Sistema renina-angiotensina e hipertrofia ventricular esquerda JO - Rev Bras Hipertens. VL - 3 ID - Oigman2000 ER - TY - STD TI - Sociedade Brasileira de Cardiologia. Diretrizes para cardiologistas sobre excesso de peso e risco cardiovascular. ID - ref49 ER - TY - JOUR AU - Bray, G. AU - Bellanger, T. PY - 2006 DA - 2006// TI - Epidemiology, trends, and morbidities of obesity and the metabolic syndrome JO - Endocrine VL - 29 UR - https://doi.org/10.1385/ENDO:29:1:109 DO - 10.1385/ENDO:29:1:109 ID - Bray2006 ER - TY - JOUR AU - Lamers, D. AU - Famulla, S. AU - Wronkowitz, N. AU - Hartwig, S. AU - Lehr, S. AU - Ouwens, D. PY - 2011 DA - 2011// TI - Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome JO - Diabetes VL - 60 UR - https://doi.org/10.2337/db10-1707 DO - 10.2337/db10-1707 ID - Lamers2011 ER - TY - JOUR AU - Xiao, C. AU - Dash, S. AU - Morgantini, C. AU - Lewis, G. F. PY - 2014 DA - 2014// TI - New and emerging regulators of intestinal lipoprotein secretion JO - Atherosclerosis. VL - 233 UR - https://doi.org/10.1016/j.atherosclerosis.2013.12.047 DO - 10.1016/j.atherosclerosis.2013.12.047 ID - Xiao2014 ER - TY - JOUR AU - Hinnouho, G. -. M. AU - Czernichow, S. AU - Dugravot, A. AU - Batty, G. AU - Kivimaki, M. AU - Singh-Manoux, A. PY - 2013 DA - 2013// TI - Metabolically healthy obesity and risk of mortality JO - Diabetes Care. VL - 36 UR - https://doi.org/10.2337/dc12-1654 DO - 10.2337/dc12-1654 ID - Hinnouho2013 ER - TY - JOUR AU - Phillips, C. M. PY - 2013 DA - 2013// TI - Metabolically healthy obesity: definitions, determinants and clinical implications JO - Rev Endocr Metab Disord. VL - 14 UR - https://doi.org/10.1007/s11154-013-9252-x DO - 10.1007/s11154-013-9252-x ID - Phillips2013 ER - TY - JOUR AU - Munckhof, I. C. L. AU - Kurilshikov, A. AU - TerHorst, R. AU - Riksen, N. P. AU - Joosten, L. A. B. AU - Zhernakova, A. PY - 2018 DA - 2018// TI - Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies JO - Obes Rev. VL - 19 UR - https://doi.org/10.1111/obr.12750 DO - 10.1111/obr.12750 ID - Munckhof2018 ER - TY - JOUR AU - Wang, Z. AU - Klipfell, E. AU - Bennett, B. J. AU - Koeth, R. AU - Levison, B. S. AU - Dugar, B. PY - 2011 DA - 2011// TI - Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease JO - Nature VL - 472 UR - https://doi.org/10.1038/nature09922 DO - 10.1038/nature09922 ID - Wang2011 ER - TY - JOUR AU - Verpeut, J. L. AU - Bello, N. T. PY - 2014 DA - 2014// TI - Drug safety evaluation of naltrexone/bupropion for the treatment of obesity JO - Expert Opin Drug Saf. VL - 13 ID - Verpeut2014 ER - TY - JOUR AU - Jain, S. S. AU - Ramanand, S. J. AU - Ramanand, J. B. AU - Akat, P. B. AU - Patwardhan, M. H. AU - Joshi, S. R. PY - 2011 DA - 2011// TI - Evaluation of efficacy and safety of orlistat in obese patients JO - Indian J Endocrinol Metab. VL - 15 UR - https://doi.org/10.4103/2230-8210.81938 DO - 10.4103/2230-8210.81938 ID - Jain2011 ER - TY - JOUR AU - Padwal, R. S. AU - Majumdar, S. R. PY - 2007 DA - 2007// TI - Drug treatments for obesity: orlistat, sibutramine, and rimonabant JO - The Lancet. VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60033-6 DO - 10.1016/S0140-6736(07)60033-6 ID - Padwal2007 ER - TY - JOUR AU - Faria, A. AU - Mancini, M. AU - Melo, M. AU - Cercato, C. AU - Halpern, A. PY - 2010 DA - 2010// TI - Progressos recentes e novas perspectivas em famacologia da obesidade JO - Arq Bras Endocrinol Metab. VL - 54 UR - https://doi.org/10.1590/S0004-27302010000600003 DO - 10.1590/S0004-27302010000600003 ID - Faria2010 ER - TY - JOUR AU - Pi-Sunyer, X. AU - Astrup, A. AU - Fujioka, K. AU - Greenway, F. AU - Halpern, A. AU - Krempf, M. PY - 2015 DA - 2015// TI - A randomized, controlled trial of 3.0 mg of liraglutide in weight management JO - N Engl J Med. VL - 373 UR - https://doi.org/10.1056/NEJMoa1411892 DO - 10.1056/NEJMoa1411892 ID - Pi-Sunyer2015 ER - TY - JOUR AU - Secher, A. AU - Jelsing, J. AU - Baquero, A. F. AU - Hecksher-Sørensen, J. AU - Cowley, M. A. AU - Dalbøge, L. S. PY - 2014 DA - 2014// TI - The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss JO - J Clin Invest VL - 124 UR - https://doi.org/10.1172/JCI75276 DO - 10.1172/JCI75276 ID - Secher2014 ER - TY - JOUR AU - Farr, O. M. AU - Sofopoulos, M. AU - Tsoukas, M. A. AU - Dincer, F. AU - Thakkar, B. AU - Sahin-Efe, A. PY - 2016 DA - 2016// TI - GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial JO - Diabetologia VL - 59 UR - https://doi.org/10.1007/s00125-016-3874-y DO - 10.1007/s00125-016-3874-y ID - Farr2016 ER - TY - JOUR AU - Wadden, T. A. AU - Hollander, P. AU - Klein, S. AU - Niswender, K. AU - Woo, V. AU - Hale, P. M. PY - 2013 DA - 2013// TI - Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study JO - Int J Obes (Lond). VL - 37 UR - https://doi.org/10.1038/ijo.2013.120 DO - 10.1038/ijo.2013.120 ID - Wadden2013 ER - TY - JOUR AU - Roux, C. W. AU - Astrup, A. AU - Fujioka, K. AU - Greenway, F. AU - Lau, D. C. W. AU - Gaal, L. PY - 2017 DA - 2017// TI - 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial JO - Lancet. VL - 389 UR - https://doi.org/10.1016/S0140-6736(17)30069-7 DO - 10.1016/S0140-6736(17)30069-7 ID - Roux2017 ER - TY - JOUR AU - Davies, M. J. AU - Aronne, L. J. AU - Caterson, I. D. AU - Thomsen, A. B. AU - Jacobsen, P. B. AU - Marso, S. P. PY - 2018 DA - 2018// TI - Liraglutide and cardiovascular outcomes in adults with overweight or obesity: a post hoc analysis from SCALE randomized controlled trials JO - Diabetes Obes Metab VL - 20 UR - https://doi.org/10.1111/dom.13125 DO - 10.1111/dom.13125 ID - Davies2018 ER - TY - JOUR AU - Marso, S. P. AU - Daniels, G. H. AU - Brown-Frandsen, K. AU - Kristensen, P. AU - Mann, J. F. AU - Nauck, M. A. PY - 2016 DA - 2016// TI - Liraglutide and cardiovascular outcomes in type 2 diabetes JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1603827 DO - 10.1056/NEJMoa1603827 ID - Marso2016 ER - TY - JOUR AU - Bohula, E. A. AU - Scirica, B. M. AU - Fanola, C. AU - Inzucchi, S. E. AU - Keech, A. AU - McGuire, D. K. PY - 2018 DA - 2018// TI - Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial JO - Am Heart J VL - 202 UR - https://doi.org/10.1016/j.ahj.2018.03.012 DO - 10.1016/j.ahj.2018.03.012 ID - Bohula2018 ER - TY - JOUR AU - Mahgerefteh, B. AU - Vigue, M. AU - Freestone, Z. AU - Silver, S. AU - Nguyen, Q. PY - 2013 DA - 2013// TI - New drug therapies for the treatment of overweight and obese patients JO - Am Health Drug Benefits. VL - 6 ID - Mahgerefteh2013 ER - TY - JOUR AU - Bohula, E. AU - Wiviott, S. AU - McGuire, D. AU - Inzucchi, S. AU - Kuder, J. AU - Im, K. PY - 2018 DA - 2018// TI - Cardiovascular safety of lorcaserin in overweight or obese patients JO - N Engl J Med VL - 379 UR - https://doi.org/10.1056/NEJMoa1808721 DO - 10.1056/NEJMoa1808721 ID - Bohula2018 ER - TY - JOUR AU - Tek, C. PY - 2016 DA - 2016// TI - Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives JO - Patient Prefer Adherence. VL - 10 ID - Tek2016 ER - TY - JOUR AU - Yanovski, S. Z. AU - Yanovski, J. A. PY - 2015 DA - 2015// TI - Naltrexone extended-release plus bupropion extended-release for treatment of obesity JO - JAMA VL - 313 UR - https://doi.org/10.1001/jama.2015.1617 DO - 10.1001/jama.2015.1617 ID - Yanovski2015 ER - TY - JOUR AU - Nissen, S. E. AU - Wolski, K. E. AU - Prcela, L. AU - Wadden, T. AU - Buse, J. B. AU - Bakris, G. PY - 2016 DA - 2016// TI - Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a randomized clinical trial JO - JAMA VL - 315 UR - https://doi.org/10.1001/jama.2016.1558 DO - 10.1001/jama.2016.1558 ID - Nissen2016 ER - TY - JOUR AU - James, W. AU - Caterson, I. AU - Coutinho, W. AU - Finer, N. AU - Gaal, L. AU - Maggioni, A. PY - 2010 DA - 2010// TI - Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1003114 DO - 10.1056/NEJMoa1003114 ID - James2010 ER - TY - JOUR AU - Wadden, T. AU - Berkowitz, R. AU - Womble, L. AU - Sarwer, D. AU - Phelan, S. AU - Cato, R. PY - 2005 DA - 2005// TI - Randomized trial of lifestyle modification and pharmacotherapy for obesity JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050156 DO - 10.1056/NEJMoa050156 ID - Wadden2005 ER -